Position in GILD
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$8,058,091
-$2,503,088 QoQ
Shares Held
63,781
-15.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#470
of 2,267 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Banque Cantonale Vaudoise holds $123,482,590 across 10 Drug Manufacturers - General names. GILD ranks #6 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,866 | $26,226,738 | |
| 2 | JNJ |
Johnson & Johnson
|
90,804 | $23,061,491 | |
| 3 | ABBV |
AbbVie Inc.
|
89,306 | $22,472,961 | |
| 4 | MRK |
Merck & Co., Inc.
|
105,147 | $13,511,389 | |
| 5 | AZN |
Astrazeneca PLC
|
60,462 | $11,464,804 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
63,781 | $8,058,091 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
136,299 | $7,853,548 | |
| 8 | PFE |
Pfizer Inc
|
286,435 | $6,897,354 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,058,091 | 63,781 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $10,561,179 | 75,778 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $8,710,121 | 70,964 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $8,910,858 | 80,278 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,708,711 | 96,588 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $11,927,834 | 106,451 | Shares | Sole | 2025-05-08 | |
| 2024-09-30 | $12,449,401 | 148,490 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $10,176,989 | 148,331 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $9,366,184 | 127,866 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $8,816,804 | 108,836 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $7,726,538 | 103,103 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $9,109,828 | 118,202 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $12,008,414 | 144,732 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $12,119,186 | 141,167 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $7,796,567 | 126,383 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $7,966,010 | 128,879 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $8,103,629 | 136,310 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $9,115,096 | 125,535 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,526,310 | 122,066 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $8,689,856 | 126,196 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $8,463,039 | 130,946 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $7,541,232 | 129,441 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $7,736,667 | 122,435 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $7,166,576 | 93,145 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $7,501,642 | 100,343 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||